Search Prime Grants

72061722CA00003

Cooperative Agreement

Overview

Grant Description
To increase availability, accessibility, and utilization of quality integrated TB/HIV and MDR TB services.
Awardee
The Infectious Diseases Institute
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
98.001 - USAID Foreign Assistance for Programs Overseas
Awarding / Funding Agency
U.S. Mission to Uganda [USAID - OM]
Place of Performance
Uganda
Geographic Scope
Foreign
Related Opportunity
72061721RFA00005
Analysis Notes
Amendment Since initial award the total obligations have increased 3605% from $400,000 to $14,821,796.
The Infectious Diseases Institute was awarded Enhancing TB/HIV & MDR TB Services: A Comprehensive Approach Cooperative Agreement 72061722CA00003 worth $14,821,796 from U.S. Mission to Uganda in October 2021 with work to be completed primarily in Uganda. The grant has a duration of 5 years and was awarded through assistance program 98.001 USAID Foreign Assistance for Programs Overseas.

Status
(Ongoing)

Last Modified 10/7/24

Period of Performance
10/29/21
Start Date
10/28/26
End Date
81.0% Complete

Funding Split
$14.8M
Federal Obligation
$0.0
Non-Federal Obligation
$14.8M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to 72061722CA00003

Transaction History

Modifications to 72061722CA00003

Additional Detail

Award ID FAIN
72061722CA00003
SAI Number
72061722CA00003-P009
Award ID URI
SAI NOT AVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
720617 USAID/UGANDA
Funding Office
720617 USAID/UGANDA
Awardee UEI
THLMFMXSXTC4
Awardee CAGE
SCX13
Performance District
Not Applicable

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Global Health Programs, State (019-1031) International development and humanitarian assistance Grants, subsidies, and contributions (41.0) $8,709,927 100%
Modified: 10/7/24